SARAH FOSTER, FNP-C
Family Nurse Practitioner · LEES SUMMIT, MO
Individual Active NPI 1194365478
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 188 | 83,913 | $6,766,544 | $2,408,545 | $1,913,886 |
| 2023 | 185 | 57,544 | $6,273,015 | $2,259,786 | $1,801,038 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 10,800 | $22 | $18 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 6,090 | $18 | $14 |
| J2357 | Injection, omalizumab, 5 mg | 3,315 | $38 | $30 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 3,000 | $18 | $14 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,650 | $32 | $25 |
| J3245 | Injection, tildrakizumab, 1 mg | 2,100 | $136 | $108 |
| J0517 | Injection, benralizumab, 1 mg | 750 | $165 | $131 |
| 96372 | Injection of drug or substance under skin or into muscle | 230 | $11 | $9 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 218 | $0 | $0 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 108 | $101 | $79 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 107 | $48 | $38 |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 86 | $16 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 202001231 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Missouri
- NPI 1720515257
- NPI 1689604944
- NPI 1821469982
- NPI 1245089408
- NPI 1821868639
- NPI 1194661298
- NPI 1780885970
- NPI 1548875354
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.